Correlation Between Cingulate Warrants and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Monte Rosa.
Diversification Opportunities for Cingulate Warrants and Monte Rosa
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cingulate and Monte is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Monte Rosa go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Monte Rosa
Assuming the 90 days horizon Cingulate Warrants is expected to generate 4.06 times more return on investment than Monte Rosa. However, Cingulate Warrants is 4.06 times more volatile than Monte Rosa Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 5.13 in Cingulate Warrants on December 29, 2024 and sell it today you would earn a total of 0.08 from holding Cingulate Warrants or generate 1.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 96.72% |
Values | Daily Returns |
Cingulate Warrants vs. Monte Rosa Therapeutics
Performance |
Timeline |
Cingulate Warrants |
Monte Rosa Therapeutics |
Cingulate Warrants and Monte Rosa Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cingulate Warrants and Monte Rosa
The main advantage of trading using opposite Cingulate Warrants and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd | Cingulate Warrants vs. Dermata Therapeutics Warrant |
Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |